Clinical trial

The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients

NCT01270191

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Exenatide Normalized identity: exenatideView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Humulin-N Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-11-01

PhasePHASE4

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

ExenatideDRUG · verified · RxNorm: exenatide

Humulin-NDRUG

Sponsors & collaborators

Taipei Veterans General Hospital, Taiwanlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01270191 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.